A Phase 2/3 interventional study of helium:oxygen mixture in Bronchiolitis and Chronic Bronchitis, sponsored by Baqiyatallah Medical Sciences University. Completed at 1 site in Iran, Islamic Republic of. Open to male participants aged 38 Years to 59 Years. Per ClinicalTrials.gov, last updated 2008-03-25.
Sponsored by Baqiyatallah Medical Sciences University · Phase 2/3, Interventional, and Supportive care
to assess the effect of Heliox with Noninvasive positive pressure ventilation to decrease dyspnea and improve physiologic and respiratory measures in patients with a previous exposure to Sulfur Mustard gas.
360 studies on the registry are indexed under Bronchiolitis; 43 are open to participants now.
This study's enrollment of 23 is below the median of 80 across 249 interventional studies indexed under Bronchiolitis.
Browse Bronchiolitis studies →Baqiyatallah Medical Sciences University is the lead sponsor of 31 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: helium:oxygen mixture
This study is completed, as verified in Mar 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Baqiyatallah Medical Sciences University